Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Knoll Capital Management
investment firm
About
Knoll Capital Management is a venture capital firm thats invests in firms focused in information technology sector.
Highlights
Details
- Operating Status
- Active
- Investor Type
- Venture Capital
Investments
Number of Investments
Number of Lead Investments
4
0
Knoll Capital Management has made 4 investments. Their most recent investment was on
Nov 29, 2017, when electroCore raised $34M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Nov 29, 2017
electroCore
|
Series B | $34M | Health Care | — |
|
Nov 6, 2017
Exicure
|
Series Unknown | $11.20M | Biotechnology | — |
|
Feb 21, 2017
Bristol Myers Squibb
|
Post-IPO Equity | $80M | Biotechnology | — |
|
Nov 1, 2016
Biohaven Pharmaceutical
|
Series Unknown | $80M | Biotechnology | — |
Exits
Knoll Capital Management has had 4 exits. Knoll Capital Management most notable exits include Exicure , electroCore
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Dec 19, 2019 | Exicure | IPO | Biotechnology | Detail |
| Jun 21, 2018 | electroCore | IPO | Health Care | Detail |
| May 5, 2017 | Biohaven Pharmaceutical | M&A | Biotechnology | Detail |
| Jan 1, 1972 | Bristol Myers Squibb | IPO | Biotechnology | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
